Andere Kunden interessierten sich auch für
![New multi-factorial therapies for ataxic cerebral palsy]( "New multi-factorial therapies for ataxic cerebral palsy")
New multi-factorial therapies for ataxic cerebral palsy30,99 €![Treatment of Opioid withdrawal symptoms using different drug therapies]( "Treatment of Opioid withdrawal symptoms using different drug therapies")
Treatment of Opioid withdrawal symptoms using different drug therapies39,99 €![Alternative therapies for reducing menopausal problems]( "Alternative therapies for reducing menopausal problems")
Alternative therapies for reducing menopausal problems30,99 €![Generation of Long Acting Therapies Using Glycosylated Linkers]( "Generation of Long Acting Therapies Using Glycosylated Linkers")
Generation of Long Acting Therapies Using Glycosylated Linkers58,99 €![Acute Myocardial Infarction Behavior]( "Acute Myocardial Infarction Behavior")
Acute Myocardial Infarction Behavior36,99 €![Outcome measurements evaluating Quality of Life among LVAD patients]( "Outcome measurements evaluating Quality of Life among LVAD patients")
Outcome measurements evaluating Quality of Life among LVAD patients16,99 €![Heparin. New biochemical and medical aspects]( "Heparin. New biochemical and medical aspects")
Heparin. New biochemical and medical aspects129,95 €
The prevalence of ischemic heart diseases, especially acute myocardial infarction and its incidence has increased at early ages, and therapies in acute stages of myocardial infarction play a vital role in the prognosis and quality of patients' life. Fibrinolytic treatment of acute myocardial infarction must be performed as early as the disease begins. Since the reduction of pre-hospital delay is difficult, it is emphasized. This study aims to evaluate the clinical outcome of thrombolytic therapy in patients with acute myocardial infarction who referred to Ayatollah Taleghani Educational-Medical Center of Urmia in 2013-2016.